免疫細胞療法のグローバル市場2023年:T細胞療法、ナチュラルキラー(NK)細胞療法、その他

◆英語タイトル:Global Immune Cell Therapy Market Research Report 2023

QYResearchが発行した調査報告書(QYR23MA8538)◆商品コード:QYR23MA8538
◆発行会社(リサーチ会社):QYResearch
◆発行日:2023年3月
◆ページ数:83
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後2-3営業日)
◆調査対象地域:グローバル
◆産業分野:新技術
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,900 ⇒換算¥429,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD4,350 ⇒換算¥643,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD5,800 ⇒換算¥858,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

本調査レポートは世界の免疫細胞療法市場について調査・分析し、世界の免疫細胞療法市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析(T細胞療法、ナチュラルキラー(NK)細胞療法、その他)、用途別セグメント分析(胃がん、肺がん、大腸がん、食道がん、膵臓がん、その他)、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Adaptimmune、Altor Bioscience Corporation、Cellectis、Juno Therapeutics、Kite Pharma、Novartis、Takara Bio、Unum Therapeuticsなどが含まれています。世界の免疫細胞療法市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX%です。COVID-19とロシア・ウクライナ戦争の影響は、免疫細胞療法市場規模を推定する際に考慮しました。

・免疫細胞療法市場の概要
- 免疫細胞療法のタイプ別セグメント
- 世界の免疫細胞療法市場規模:タイプ別分析(T細胞療法、ナチュラルキラー(NK)細胞療法、その他)
- 免疫細胞療法の用途別セグメント
- 世界の免疫細胞療法市場規模:用途別分析(胃がん、肺がん、大腸がん、食道がん、膵臓がん、その他)
- 世界の免疫細胞療法市場規模予測(2018年-2029年)

・免疫細胞療法市場の成長トレンド
- 免疫細胞療法の地域別市場規模(2018年-2029年)
- 免疫細胞療法市場ダイナミクス
- 免疫細胞療法の業界動向
- 免疫細胞療法市場の成長ドライバ、課題、阻害要因

・主要企業別競争状況
- 企業別市場シェア
- 世界の主要企業、業界ランキング分析
- 市場への参入、M&A動向

・タイプ別セグメント:T細胞療法、ナチュラルキラー(NK)細胞療法、その他
- 世界の免疫細胞療法のタイプ別市場規模(2018年-2023年)
- 世界の免疫細胞療法のタイプ別市場規模(2024年-2029年)

・用途別セグメント:胃がん、肺がん、大腸がん、食道がん、膵臓がん、その他
- 世界の免疫細胞療法の用途別市場規模(2018年-2023年)
- 世界の免疫細胞療法の用途別市場規模(2024年-2029年)

・免疫細胞療法の地域別市場規模
- 北米の免疫細胞療法市場規模(2018年-2029年)
- アメリカの免疫細胞療法市場規模(2018年-2029年)
- ヨーロッパの免疫細胞療法市場規模(2018年-2029年)
- アジア太平洋の免疫細胞療法市場規模(2018年-2029年)
- 中国の免疫細胞療法市場規模(2018年-2029年)
- 日本の免疫細胞療法市場規模(2018年-2029年)
- 韓国の免疫細胞療法市場規模(2018年-2029年)
- インドの免疫細胞療法市場規模(2018年-2029年)
- オーストラリアの免疫細胞療法市場規模(2018年-2029年)
- 中南米の免疫細胞療法市場規模(2018年-2029年)
- 中東・アフリカの免疫細胞療法市場規模(2018年-2029年)

・主要企業のプロファイル:企業情報、事業概要、売上、動向
Adaptimmune、Altor Bioscience Corporation、Cellectis、Juno Therapeutics、Kite Pharma、Novartis、Takara Bio、Unum Therapeutics

・アナリストの観点/結論

・調査方法とデータソース

Highlights
The global Immune Cell Therapy market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Immune Cell Therapy is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Immune Cell Therapy is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Immune Cell Therapy in Stomach Cancer is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Immune Cell Therapy include Adaptimmune, Altor Bioscience Corporation, Cellectis, Juno Therapeutics, Kite Pharma, Novartis, Takara Bio and Unum Therapeutics, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Immune Cell Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Immune Cell Therapy.
The Immune Cell Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Immune Cell Therapy market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Immune Cell Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Adaptimmune
Altor Bioscience Corporation
Cellectis
Juno Therapeutics
Kite Pharma
Novartis
Takara Bio
Unum Therapeutics
Segment by Type
T Cell Therapy
Natural Killer (NK) Cell Therapy
Other
Segment by Application
Stomach Cancer
Lung Cancer
Colorectal Cancer
Esophageal Cancer
Pancreatic Cancer
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Immune Cell Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Immune Cell Therapy Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 T Cell Therapy
1.2.3 Natural Killer (NK) Cell Therapy
1.2.4 Other
1.3 Market by Application
1.3.1 Global Immune Cell Therapy Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Stomach Cancer
1.3.3 Lung Cancer
1.3.4 Colorectal Cancer
1.3.5 Esophageal Cancer
1.3.6 Pancreatic Cancer
1.3.7 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Immune Cell Therapy Market Perspective (2018-2029)
2.2 Immune Cell Therapy Growth Trends by Region
2.2.1 Global Immune Cell Therapy Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Immune Cell Therapy Historic Market Size by Region (2018-2023)
2.2.3 Immune Cell Therapy Forecasted Market Size by Region (2024-2029)
2.3 Immune Cell Therapy Market Dynamics
2.3.1 Immune Cell Therapy Industry Trends
2.3.2 Immune Cell Therapy Market Drivers
2.3.3 Immune Cell Therapy Market Challenges
2.3.4 Immune Cell Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Immune Cell Therapy Players by Revenue
3.1.1 Global Top Immune Cell Therapy Players by Revenue (2018-2023)
3.1.2 Global Immune Cell Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Immune Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Immune Cell Therapy Revenue
3.4 Global Immune Cell Therapy Market Concentration Ratio
3.4.1 Global Immune Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Immune Cell Therapy Revenue in 2022
3.5 Immune Cell Therapy Key Players Head office and Area Served
3.6 Key Players Immune Cell Therapy Product Solution and Service
3.7 Date of Enter into Immune Cell Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Immune Cell Therapy Breakdown Data by Type
4.1 Global Immune Cell Therapy Historic Market Size by Type (2018-2023)
4.2 Global Immune Cell Therapy Forecasted Market Size by Type (2024-2029)
5 Immune Cell Therapy Breakdown Data by Application
5.1 Global Immune Cell Therapy Historic Market Size by Application (2018-2023)
5.2 Global Immune Cell Therapy Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Immune Cell Therapy Market Size (2018-2029)
6.2 North America Immune Cell Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Immune Cell Therapy Market Size by Country (2018-2023)
6.4 North America Immune Cell Therapy Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Immune Cell Therapy Market Size (2018-2029)
7.2 Europe Immune Cell Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Immune Cell Therapy Market Size by Country (2018-2023)
7.4 Europe Immune Cell Therapy Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Immune Cell Therapy Market Size (2018-2029)
8.2 Asia-Pacific Immune Cell Therapy Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Immune Cell Therapy Market Size by Region (2018-2023)
8.4 Asia-Pacific Immune Cell Therapy Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Immune Cell Therapy Market Size (2018-2029)
9.2 Latin America Immune Cell Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Immune Cell Therapy Market Size by Country (2018-2023)
9.4 Latin America Immune Cell Therapy Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Immune Cell Therapy Market Size (2018-2029)
10.2 Middle East & Africa Immune Cell Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Immune Cell Therapy Market Size by Country (2018-2023)
10.4 Middle East & Africa Immune Cell Therapy Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Adaptimmune
11.1.1 Adaptimmune Company Detail
11.1.2 Adaptimmune Business Overview
11.1.3 Adaptimmune Immune Cell Therapy Introduction
11.1.4 Adaptimmune Revenue in Immune Cell Therapy Business (2018-2023)
11.1.5 Adaptimmune Recent Development
11.2 Altor Bioscience Corporation
11.2.1 Altor Bioscience Corporation Company Detail
11.2.2 Altor Bioscience Corporation Business Overview
11.2.3 Altor Bioscience Corporation Immune Cell Therapy Introduction
11.2.4 Altor Bioscience Corporation Revenue in Immune Cell Therapy Business (2018-2023)
11.2.5 Altor Bioscience Corporation Recent Development
11.3 Cellectis
11.3.1 Cellectis Company Detail
11.3.2 Cellectis Business Overview
11.3.3 Cellectis Immune Cell Therapy Introduction
11.3.4 Cellectis Revenue in Immune Cell Therapy Business (2018-2023)
11.3.5 Cellectis Recent Development
11.4 Juno Therapeutics
11.4.1 Juno Therapeutics Company Detail
11.4.2 Juno Therapeutics Business Overview
11.4.3 Juno Therapeutics Immune Cell Therapy Introduction
11.4.4 Juno Therapeutics Revenue in Immune Cell Therapy Business (2018-2023)
11.4.5 Juno Therapeutics Recent Development
11.5 Kite Pharma
11.5.1 Kite Pharma Company Detail
11.5.2 Kite Pharma Business Overview
11.5.3 Kite Pharma Immune Cell Therapy Introduction
11.5.4 Kite Pharma Revenue in Immune Cell Therapy Business (2018-2023)
11.5.5 Kite Pharma Recent Development
11.6 Novartis
11.6.1 Novartis Company Detail
11.6.2 Novartis Business Overview
11.6.3 Novartis Immune Cell Therapy Introduction
11.6.4 Novartis Revenue in Immune Cell Therapy Business (2018-2023)
11.6.5 Novartis Recent Development
11.7 Takara Bio
11.7.1 Takara Bio Company Detail
11.7.2 Takara Bio Business Overview
11.7.3 Takara Bio Immune Cell Therapy Introduction
11.7.4 Takara Bio Revenue in Immune Cell Therapy Business (2018-2023)
11.7.5 Takara Bio Recent Development
11.8 Unum Therapeutics
11.8.1 Unum Therapeutics Company Detail
11.8.2 Unum Therapeutics Business Overview
11.8.3 Unum Therapeutics Immune Cell Therapy Introduction
11.8.4 Unum Therapeutics Revenue in Immune Cell Therapy Business (2018-2023)
11.8.5 Unum Therapeutics Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 免疫細胞療法のグローバル市場2023年:T細胞療法、ナチュラルキラー(NK)細胞療法、その他(Global Immune Cell Therapy Market Research Report 2023)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆